Search results
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Business Standard India· 4 days agoShares of pharmaceutical companies were in focus, and rallied up to 12 per cent on the BSE in...
Zydus Life shares gain on licensing agreement with Dr Reddy’s to market Pertuzumab Biosimilar
CNBC Awaaz· 6 days agoZydus Lifesciences share price was up marginally percent in the opening trade on July 1 after the...
Mark to Market: Can Dr Reddy’s buy its way out of a slump?
Livemint· 4 days agoDr. Reddy’s has announced the acquisition of British pharma firm Haleon's global portfolio of...
Stocks in news: HDFC Bank, IDFC First Bank, IDBI Bank, Dr Reddy's, Lloyds Metals
The Economic Times· 3 days agoHDFC Bank advances rose 53% to Rs 24.87 lakh crore. LIC boosted IDFC First Bank's stake to 2.68%. Dr...
Dr Reddys Laboratories Ltd Stock Price: Dr Reddys Labs Share Price Today | India Infoline
India Infoline· 4 days agoDr Reddys Labs Share Price: Get the live NSE/BSE stock price of Dr Reddys Laboratories Ltd with performance, market cap, financial report, and company profile at India Infoline.
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 5 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
IT Stocks: Infosys, TCS, HCL Tech, Wipro, Persistent Systems Share Price Target By Brokerages
Latest India News· 5 days agoGlobal brokerages have revised their stance on selected information technology (IT) stocks. The list includes names such as Wipro, Infosys, TCS, and others. Here is a revised list of IT stocks by the brokerages.
Cipla vs Competitors: Analysing success behind Cipla's growth
Business Today· 3 days agoCompeting with giants like Sun Pharma and Dr. Reddy's Laboratories, Cipla's steadfast growth trajectory is reflected in metrics such as Cipla share < ...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 2 days agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Vraj Iron hits upper circuit after listing at 16% premium over issue price
Business Standard India· 4 days agoVraj Iron and Steel listed at Rs 240 apiece on both the BSE and NSE, marking a premium of 15.94 per...